McIlrath & Eck’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
DSA
RCMNY
McIlrath & Eck's VTRS Position: Q1 2026 in Review
McIlrath & Eck reduced its Viatris (VTRS) stake by 3.3% in Q1 2026, selling an estimated $406 and leaving 862 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #999.
McIlrath & Eck first reported a position in VTRS in Q4 2017 and has held it in 27 quarters since. The position peaked at $31K in Q4 2020. 1,030 funds tracked by Wall St. Rank hold VTRS as of Q1 2026.
- McIlrath & Eck held 862 shares of Viatris worth $11.6K as of Q1 2026.
- McIlrath & Eck sold 29 Viatris shares in Q1 2026, an estimated $406.
- Viatris made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #999 holding.
- McIlrath & Eck first reported a position in Viatris in Q4 2017 and has held it in 27 quarters since.
- McIlrath & Eck's Viatris position peaked at $31K in Q4 2020.
- 1,030 funds tracked by Wall St. Rank held Viatris as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.